Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...

Taking one last moment to look back at 2025, P!nk shared her positive outlook on 2026 -even from the hospital.

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells. Similar to CAR-T cells, these cells can be ...

Searching the IRIS Registry for the years 2016 to 2022, they found data entered for 67,855,466 patients. Applying the ICD ...